SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-107328
Filing Date
2016-06-07
Accepted
2016-06-07 17:15:45
Documents
7
Period of Report
2016-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v441902_8k.htm 8-K 28363
2 EXHIBIT 5.1 v441902_ex5-1.htm EX-5.1 8414
3 EXHIBIT 10.1 v441902_ex10-1.htm EX-10.1 50540
4 EXHIBIT 10.2 v441902_ex10-2.htm EX-10.2 201827
5 GRAPHIC image_001.jpg GRAPHIC 3870
6 GRAPHIC image_002.jpg GRAPHIC 3593
7 GRAPHIC image_003.jpg GRAPHIC 3870
  Complete submission text file 0001144204-16-107328.txt   306369
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 161702054
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences